Edwards Lifesciences Corporation Company Profile (NYSE:EW)

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation logoEdwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company manufactures heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. It develops hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Company conducts operations around the world and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease. The Company's products and technologies it offers to treat advanced cardiovascular disease are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: EW
  • CUSIP: 28176E10
Key Metrics:
  • Previous Close: $89.74
  • 50 Day Moving Average: $94.82
  • 200 Day Moving Average: $103.16
  • 52-Week Range: $81.12 - $121.75
  • Trailing P/E Ratio: 34.38
  • Foreward P/E Ratio: 24.07
  • P/E Growth: 1.63
  • Market Cap: $19.18B
  • Outstanding Shares: 213,699,000
  • Beta: 0.53
  • Net Margins: 19.22%
  • Return on Equity: 25.00%
  • Return on Assets: 15.04%
  • Debt-to-Equity Ratio: 0.31%
  • Current Ratio: 4.21%
  • Quick Ratio: 3.46%
Additional Links:
Companies Related to Edwards Lifesciences Corporation:

Analyst Ratings

Consensus Ratings for Edwards Lifesciences Corporation (NYSE:EW) (?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 18 Buy Ratings
Consensus Rating:Buy (Score: 2.68)
Consensus Price Target: $116.50 (25.71% upside)

Analysts' Ratings History for Edwards Lifesciences Corporation (NYSE:EW)
DateFirmActionRatingPrice TargetDetails
2/21/2017Northland SecuritiesReiterated RatingPositiveView Rating Details
2/8/2017Credit Suisse GroupSet Price TargetBuy$120.00View Rating Details
2/5/2017Deutsche Bank AGReiterated RatingHold$100.00View Rating Details
2/2/2017Canaccord GenuitySet Price TargetBuy$140.00View Rating Details
2/2/2017Leerink SwannDowngradeOutperform -> Market PerformView Rating Details
2/2/2017BTIG ResearchDowngradeBuy -> NeutralView Rating Details
1/3/2017GuggenheimUpgradeNeutral -> Buy$120.00View Rating Details
12/10/2016JMP SecuritiesReiterated RatingEqual Weight$130.00View Rating Details
12/10/2016Barclays PLCReiterated RatingEqual Weight$100.00View Rating Details
12/9/2016Jefferies Group LLCReiterated RatingBuy$115.00View Rating Details
12/7/2016Cowen and CompanyReiterated RatingOutperform -> Buy$130.00 -> $120.00View Rating Details
12/1/2016J P Morgan Chase & CoSet Price TargetBuy$120.00View Rating Details
11/28/2016Evercore ISIReiterated RatingHold$105.00View Rating Details
10/26/2016RBC Capital MarketsReiterated RatingOutperform$130.00 -> $123.00View Rating Details
10/26/2016Stifel NicolausLower Price TargetBuy$122.00 -> $114.00View Rating Details
10/26/2016Royal Bank Of CanadaLower Price TargetOutperform$130.00 -> $123.00View Rating Details
9/11/2016Wells Fargo & CompanyReiterated RatingBuyView Rating Details
8/19/2016Morgan StanleyReiterated RatingBuy$140.00View Rating Details
7/27/2016Citigroup Inc.Boost Price TargetSell$86.00 -> $94.00View Rating Details
7/27/2016BMO Capital MarketsReiterated RatingBuy$120.00View Rating Details
7/27/2016Bank of America CorpUpgradeNeutral -> Buy$130.00View Rating Details
6/21/2016William BlairReiterated RatingOutperformView Rating Details
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$123.00View Rating Details
4/8/2016Goldman Sachs Group, Inc. (The)Boost Price Target$100.00 -> $125.00View Rating Details
3/17/2016NomuraInitiated CoverageBuy$101.00View Rating Details
3/8/2016SunTrust Banks, Inc.Reiterated RatingBuyView Rating Details
1/4/2016Sterne Agee CRTBoost Price TargetBuy$90.00 -> $92.00View Rating Details
(Data available from 2/21/2015 forward)


Earnings History for Edwards Lifesciences Corporation (NYSE:EW)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/1/2017Q416$0.72$0.75$760.85 million$767.70 millionViewN/AView Earnings Details
10/25/2016Q316$0.68$0.68$749.14 million$739.40 millionViewN/AView Earnings Details
7/26/2016Q216$0.70$0.76$724.26 million$759.30 millionViewN/AView Earnings Details
4/26/2016Q116$0.66$0.71$664.53 million$697.30 millionViewN/AView Earnings Details
2/2/2016Q415$0.62$0.63$647.44 million$671.10 millionViewN/AView Earnings Details
10/26/2015Q315$0.98$1.07$598.29 million$615.00 millionViewN/AView Earnings Details
7/28/2015Q215$1.05$1.13$604.97 million$616.80 millionViewN/AView Earnings Details
4/23/2015Q115$1.04$1.12$585.16 million$590.30 millionViewN/AView Earnings Details
2/3/2015Q414$0.95$1.06$610.50 million$618.00 millionViewListenView Earnings Details
10/23/2014Q314$0.72$0.80$546.10 million$607.40 millionViewListenView Earnings Details
7/29/2014Q214$0.77$0.88$545.10 million$547.00 millionViewListenView Earnings Details
4/24/2014Q114$0.69$0.76$523.10 million$522.40 millionViewListenView Earnings Details
2/3/2014Q413$0.82$0.91$533.82 million$536.00 millionViewN/AView Earnings Details
10/28/2013Q313$0.66$0.68$490.96 million$496.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013$0.76$0.82$514.59 million$517.20 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.76$0.72$518.69 million$496.70 millionViewN/AView Earnings Details
2/4/2013Q4 2012$0.77$0.77$499.46 million$510.50 millionViewN/AView Earnings Details
10/19/2012$0.56$0.58ViewN/AView Earnings Details
7/24/2012$0.66$0.67ViewN/AView Earnings Details
2/2/2012$0.59$0.62ViewN/AView Earnings Details
10/19/2011$0.39$0.38ViewN/AView Earnings Details
7/21/2011$0.50$0.49ViewN/AView Earnings Details
4/20/2011$0.42$0.51ViewN/AView Earnings Details
2/2/2011$0.53$0.55ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Edwards Lifesciences Corporation (NYSE:EW)
Current Year EPS Consensus Estimate: $3.40 EPS
Next Year EPS Consensus Estimate: $3.85 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 201611$0.51$1.25$0.83
Q2 20166$0.65$1.24$0.78
Q3 20164$0.60$0.69$0.65
Q4 20164$0.70$0.72$0.72
Q1 20174$0.83$0.85$0.84
Q2 20174$0.85$0.88$0.87
Q3 20174$0.79$0.85$0.82
Q4 20174$0.88$0.91$0.89
Q1 20183$0.90$0.95$0.93
Q2 20183$0.96$1.04$0.99
Q3 20183$0.92$0.98$0.94
Q4 20183$1.01$1.04$1.02
(Data provided by Zacks Investment Research)


Dividend History for Edwards Lifesciences Corporation (NYSE:EW)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Edwards Lifesciences Corporation (NYSE:EW)
Insider Ownership Percentage: 2.37%
Institutional Ownership Percentage: 83.99%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/16/2017Michael A. MussallemCEOSell49,100$89.63$4,400,833.00View SEC Filing  
2/3/2017Kieran GallahueDirectorBuy3,000$90.10$270,300.00View SEC Filing  
1/13/2017Michael A. MussallemCEOSell49,100$97.08$4,766,628.00View SEC Filing  
1/12/2017Donald E. Bobo, Jr.VPSell13,720$97.47$1,337,288.40View SEC Filing  
1/12/2017Dylan SidooDirectorBuy30,000$0.13$3,900.00
1/11/2017Dylan SidooDirectorBuy20,000$0.13$2,600.00
12/19/2016Michael A. MussallemCEOSell49,100$91.96$4,515,236.00View SEC Filing  
12/5/2016Huimin WangVPSell13,650$83.53$1,140,184.50View SEC Filing  
12/1/2016Larry L. WoodVPSell13,258$81.85$1,085,167.30View SEC Filing  
11/30/2016Catherine M. SzymanVPBuy12,870$83.43$1,073,744.10View SEC Filing  
11/29/2016Kieran GallahueDirectorBuy3,000$84.63$253,890.00View SEC Filing  
11/22/2016Michael A. MussallemCEOSell49,100$84.67$4,157,297.00View SEC Filing  
11/7/2016Huimin WangVPSell13,650$91.29$1,246,108.50View SEC Filing  
11/2/2016Donald E. Bobo, Jr.VPSell15,000$90.13$1,351,950.00View SEC Filing  
11/1/2016Larry L. WoodVPSell13,257$93.27$1,236,480.39View SEC Filing  
10/27/2016Michael A. MussallemCEOSell49,100$92.77$4,555,007.00View SEC Filing  
10/5/2016Huimin WangVPSell13,650$120.04$1,638,546.00View SEC Filing  
10/3/2016Larry L. WoodVPSell13,257$119.27$1,581,162.39View SEC Filing  
9/6/2016Huimin WangVPSell13,650$115.72$1,579,578.00View SEC Filing  
9/2/2016Donald E. Bobo, Jr.VPSell18,000$115.78$2,084,040.00View SEC Filing  
8/26/2016Patrick B. VerguetVPSell5,000$114.88$574,400.00View SEC Filing  
8/24/2016Patrick B. VerguetVPSell5,000$116.81$584,050.00View SEC Filing  
8/23/2016Patrick B. VerguetVPSell10,092$117.53$1,186,112.76View SEC Filing  
8/11/2016Michael A. MussallemCEOSell49,100$114.01$5,597,891.00View SEC Filing  
8/10/2016John T. CardisDirectorSell5,000$113.21$566,050.00View SEC Filing  
8/9/2016Patrick B. VerguetVPSell10,000$113.48$1,134,800.00View SEC Filing  
8/5/2016Huimin WangVPSell13,650$113.03$1,542,859.50View SEC Filing  
8/1/2016Larry L. WoodVPSell13,257$114.24$1,514,479.68View SEC Filing  
8/1/2016Schack Wesley W. VonDirectorSell6,000$113.98$683,880.00View SEC Filing  
7/29/2016Robert W.A. SellersVPSell10,000$114.33$1,143,300.00View SEC Filing  
7/28/2016Michael A. MussallemCEOSell49,100$113.31$5,563,521.00View SEC Filing  
7/5/2016Huimin WangVPSell13,650$98.44$1,343,706.00View SEC Filing  
7/1/2016Larry L. WoodVPSell13,257$98.79$1,309,659.03View SEC Filing  
6/8/2016Michael A MussallemCEOSell49,100$102.75$5,045,025.00View SEC Filing  
6/6/2016Huimin WangVPSell13,650$101.34$1,383,291.00View SEC Filing  
6/3/2016Larry L WoodVPSell13,257$101.38$1,343,994.66View SEC Filing  
5/31/2016Donald E Bobo JrVPSell18,000$99.04$1,782,720.00View SEC Filing  
5/24/2016Steven R LorangerDirectorBuy5,000$101.07$505,350.00View SEC Filing  
5/18/2016Patrick B VerguetVPSell13,000$102.75$1,335,750.00View SEC Filing  
5/17/2016Patrick B VerguetVPSell5,000$105.00$525,000.00View SEC Filing  
5/16/2016Patrick B VerguetVPSell3,000$104.62$313,860.00View SEC Filing  
5/5/2016Huimin WangVPSell13,650$103.36$1,410,864.00View SEC Filing  
5/5/2016Michael A MussallemCEOSell59,000$104.12$6,143,080.00View SEC Filing  
5/2/2016Patrick B VerguetVPSell7,000$106.86$748,020.00View SEC Filing  
4/29/2016Michael A MussallemCEOSell59,000$106.13$6,261,670.00View SEC Filing  
4/5/2016Huimin WangVPSell13,650$103.97$1,419,190.50View SEC Filing  
3/17/2016Michael A MussallemCEOSell59,000$84.39$4,979,010.00View SEC Filing  
3/7/2016Huimin WangVPSell13,650$87.17$1,189,870.50View SEC Filing  
2/18/2016Michael A. MussallemCEOSell59,000$86.94$5,129,460.00View SEC Filing  
2/18/2016Patrick B. VerguetVPSell5,000$87.00$435,000.00View SEC Filing  
2/16/2016Patrick B. VerguetVPSell8,000$81.58$652,640.00View SEC Filing  
2/5/2016Huimin WangVPSell13,650$83.46$1,139,229.00View SEC Filing  
2/4/2016Barbara J. McneilDirectorSell4,000$83.29$333,160.00View SEC Filing  
1/21/2016Patrick B. VerguetVPSell8,000$77.00$616,000.00View SEC Filing  
1/6/2016Nick DemareDirectorBuy15,000$0.08$1,200.00
1/5/2016Huimin WangVPSell13,650$78.50$1,071,525.00View SEC Filing  
1/5/2016Michael A. MussallemCEOSell59,000$79.82$4,709,380.00View SEC Filing  
12/17/2015Michael A. MussallemCEOSell59,000$81.85$4,829,150.00View SEC Filing  
12/15/2015Patrick B. VerguetVPSell8,000$80.87$646,960.00View SEC Filing  
12/4/2015Huimin WangVPSell6,880$157.96$1,086,764.80View SEC Filing  
11/27/2015Patrick B. VerguetVPSell7,500$164.50$1,233,750.00View SEC Filing  
11/23/2015Robert W.A. SellersVPSell19,200$157.13$3,016,896.00View SEC Filing  
11/17/2015Patrick B. VerguetVPSell4,000$154.50$618,000.00View SEC Filing  
11/5/2015Huimin WangVPSell6,920$156.01$1,079,589.20View SEC Filing  
11/3/2015Patrick B. VerguetVPSell4,338$158.48$687,486.24View SEC Filing  
10/30/2015Patrick B. VerguetVPSell22,000$155.09$3,411,980.00View SEC Filing  
10/29/2015Michael A MussallemCEOSell29,500$154.59$4,560,405.00View SEC Filing  
10/5/2015Huimin WangVPSell6,920$154.30$1,067,756.00View SEC Filing  
10/2/2015Patrick B. VerguetVPSell4,000$154.00$616,000.00View SEC Filing  
10/1/2015Larry L. WoodVPSell7,680$141.52$1,086,873.60View SEC Filing  
9/21/2015Michael A. MussallemCEOSell29,500$142.49$4,203,455.00View SEC Filing  
9/4/2015Huimin WangVPSell6,920$135.19$935,514.80View SEC Filing  
9/1/2015Larry L. WoodVPSell7,680$137.50$1,056,000.00View SEC Filing  
8/24/2015Michael A. MussallemCEOSell29,500$135.25$3,989,875.00View SEC Filing  
8/13/2015West Petroleum Corp. EastInsiderBuy25,000$0.12$2,875.00
7/6/2015Huimin WangVPSell6,920$143.95$996,134.00View SEC Filing  
7/1/2015Larry L WoodVPSell7,680$143.51$1,102,156.80View SEC Filing  
6/24/2015Michael A MussallemCEOSell29,500$143.71$4,239,445.00View SEC Filing  
6/5/2015Huimin WangVPSell6,920$131.39$909,218.80View SEC Filing  
6/1/2015Larry L WoodVPSell7,680$130.47$1,002,009.60View SEC Filing  
5/29/2015Patrick B VerguetVPSell9,662$131.18$1,267,461.16View SEC Filing  
5/21/2015Barbara J McneilDirectorSell2,000$132.59$265,180.00View SEC Filing  
5/19/2015Robert Marc BustinDirectorSell10,000$0.18$1,750.00
5/1/2015Larry L WoodVPSell7,680$127.12$976,281.60View SEC Filing  
4/30/2015Michael A MussallemCEOSell29,500$128.99$3,805,205.00View SEC Filing  
4/6/2015Huimin WangVPSell6,920$140.24$970,460.80View SEC Filing  
4/1/2015Larry L WoodVPSell7,680$142.06$1,091,020.80View SEC Filing  
3/31/2015Robert Marc BustinDirectorBuy15,000$0.15$2,250.00
3/26/2015Michael A MussallemCEOSell29,500$140.10$4,132,950.00View SEC Filing  
3/2/2015Larry L WoodVPSell7,680$132.62$1,018,521.60View SEC Filing  
2/6/2015Huimin WangVPSell6,920$134.79$932,746.80View SEC Filing  
1/5/2015Huimin WangVPSell6,920$126.60$876,072.00View SEC Filing  
1/5/2015Michael A MussallemCEOSell29,500$128.20$3,781,900.00View SEC Filing  
12/22/2014Michael A MussallemCEOSell29,500$133.01$3,923,795.00View SEC Filing  
11/24/2014Michael A MussallemCEOSell29,500$124.25$3,665,375.00View SEC Filing  
11/13/2014Robert W.A. SellersVPSell3,400$124.27$422,518.00View SEC Filing  
11/10/2014Patrick B VerguetVPSell5,000$123.70$618,500.00View SEC Filing  
11/7/2014Schack Wesley W VonDirectorSell3,655$123.00$449,565.00View SEC Filing  
11/5/2014Huimin WangVPSell5,600$120.26$673,456.00View SEC Filing  
10/28/2014Barbara J McneilDirectorSell1,000$117.94$117,940.00View SEC Filing  
10/28/2014Michael A MussallemCEOSell29,500$117.06$3,453,270.00View SEC Filing  
10/28/2014Patrick B VerguetVPSell15,000$117.33$1,759,950.00View SEC Filing  
10/28/2014West Petroleum Corp. EastInsiderBuy15,000$0.12$1,800.00
10/27/2014Patrick B VerguetVPSell10,000$117.00$1,170,000.00View SEC Filing  
10/27/2014West Petroleum Corp. EastInsiderBuy20,000$0.13$2,600.00
10/24/2014Donald E Bobo JrVPSell30,000$114.25$3,427,500.00View SEC Filing  
10/24/2014West Petroleum Corp. EastInsiderBuy35,000$0.14$4,725.00
10/23/2014West Petroleum Corp. EastInsiderBuy40,000$0.15$5,800.00
10/6/2014Huimin WangVPSell5,600$107.00$599,200.00View SEC Filing  
10/3/2014Donald E Bobo JrVPSell25,000$105.00$2,625,000.00View SEC Filing  
9/29/2014Michael A MussallemCEOSell29,500$102.71$3,029,945.00View SEC Filing  
9/10/2014Donald E Bobo JrVPSell25,000$100.00$2,500,000.00View SEC Filing  
9/5/2014Huimin WangVPSell5,600$98.29$550,424.00View SEC Filing  
8/27/2014Carlyn D SolomonVPSell85,200$97.85$8,336,820.00View SEC Filing  
8/27/2014Michael A MussallemCEOSell29,500$98.14$2,895,130.00View SEC Filing  
8/18/2014John T CardisDirectorSell6,000$97.92$587,520.00View SEC Filing  
8/18/2014Larry L WoodVPSell63,752$97.85$6,238,133.20View SEC Filing  
8/13/2014Patrick B VerguetVPSell7,800$95.50$744,900.00View SEC Filing  
8/5/2014Patrick B VerguetVPSell15,000$94.05$1,410,750.00View SEC Filing  
8/4/2014Patrick B VerguetVPSell5,000$93.00$465,000.00View SEC Filing  
8/1/2014Patrick B VerguetVPSell5,000$92.00$460,000.00View SEC Filing  
7/31/2014Michael A MussallemCEOSell29,500$91.98$2,713,410.00View SEC Filing  
7/31/2014Robert Alexander IngramDirectorSell12,500$90.26$1,128,250.00View SEC Filing  
7/31/2014Robert W.A. SellersVPSell8,850$91.47$809,509.50View SEC Filing  
7/30/2014Donald E Bobo JrVPSell23,270$92.00$2,140,840.00View SEC Filing  
7/7/2014Huimin WangVPSell5,600$87.79$491,624.00View SEC Filing  
6/27/2014Donald E Bobo JrVPSell25,000$87.00$2,175,000.00View SEC Filing  
6/24/2014Michael A MussallemCEOSell29,500$85.38$2,518,710.00View SEC Filing  
6/5/2014Huimin WangVPSell5,600$80.73$452,088.00View SEC Filing  
5/30/2014Barbara J McneilDirectorSell1,200$81.20$97,440.00View SEC Filing  
5/28/2014Michael A MussallemCEOSell29,500$79.33$2,340,235.00View SEC Filing  
4/14/2014Donald Bobo, Jr.VPSell25,000$82.00$2,050,000.00View SEC Filing  
4/10/2014Michael MussallemCEOSell29,500$74.71$2,203,945.00View SEC Filing  
4/7/2014Huimin WangVPSell5,600$74.03$414,568.00View SEC Filing  
3/24/2014Michael BowlinDirectorSell1,093$72.33$79,056.69View SEC Filing  
3/6/2014Robert W.A. SellersVPSell1,650$72.88$120,252.00View SEC Filing  
2/6/2014Michael MussallemCEOSell29,500$66.92$1,974,140.00View SEC Filing  
1/27/2014Michael BowlinDirectorSell1,092$68.65$74,965.80View SEC Filing  
1/9/2014Michael MussallemCEOSell29,500$67.04$1,977,680.00View SEC Filing  
1/6/2014Huimin WangVPSell5,600$67.14$375,984.00View SEC Filing  
12/11/2013Patrick VerguetVPSell10,000$62.34$623,400.00View SEC Filing  
12/5/2013Huimin WangVPSell4,650$64.65$300,622.50View SEC Filing  
12/4/2013Michael MussallemCEOSell29,500$64.90$1,914,550.00View SEC Filing  
10/9/2013Michael MussallemCEOSell29,500$72.63$2,142,585.00View SEC Filing  
10/4/2013Huimin WangVPSell4,850$72.19$350,121.50View SEC Filing  
9/12/2013Michael MussallemCEOSell29,500$71.82$2,118,690.00View SEC Filing  
9/5/2013Huimin WangVPSell4,850$71.24$345,514.00View SEC Filing  
8/8/2013Michael MussallemCEOSell29,500$72.28$2,132,260.00View SEC Filing  
8/5/2013Huimin WangVPSell4,850$72.30$350,655.00View SEC Filing  
8/1/2013Patrick VerguetVPSell20,000$73.15$1,463,000.00View SEC Filing  
7/10/2013Michael A MussallemCEOSell29,500$65.60$1,935,200.00View SEC Filing  
7/5/2013Huimin WangVPSell4,850$65.69$318,596.50View SEC Filing  
6/6/2013Michael A MussallemCEOSell29,500$66.25$1,954,375.00View SEC Filing  
6/5/2013Huimin WangVPSell4,850$65.11$315,783.50View SEC Filing  
5/13/2013Paul C RedmondVPSell5,000$67.35$336,750.00View SEC Filing  
5/8/2013Michael A MussallemCEOSell29,200$64.24$1,875,808.00View SEC Filing  
5/7/2013Thomas M AbateCFOSell15,000$63.75$956,250.00View SEC Filing  
5/3/2013Schack Wesley W VonDirectorBuy1,000$64.00$64,000.00View SEC Filing  
5/1/2013David E I PyottDirectorBuy3,000$62.95$188,850.00View SEC Filing  
5/1/2013John H Kehl JrVPSell12,500$62.72$784,000.00View SEC Filing  
4/26/2013Schack Wesley W VonDirectorBuy2,000$64.95$129,900.00View SEC Filing  
4/10/2013Michael A MussallemCEOSell35,000$83.37$2,917,950.00View SEC Filing  
3/13/2013John H Kehl JrVPSell12,500$87.75$1,096,875.00View SEC Filing  
10/5/2012Huimin WangVPSell6,250$109.88$686,750.00View SEC Filing  
10/4/2012Donald E Bobo JrVPSell11,530$110.14$1,269,914.20View SEC Filing  
8/9/2012Michael A MussallemCEOSell35,000$98.69$3,454,150.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Edwards Lifesciences Corporation (NYSE:EW)
fool.com logoAre Edwards Lifesciences Best Days Behind It? (NYSE:EW)
www.fool.com - February 21 at 9:16 AM
News IconSell-Side Analyst's Predictions: Twenty-First Century Fox, Inc. (FOX), Edwards Lifesciences Corporation (EW) - The USA Commerce (NYSE:EW)
theusacommerce.com - February 20 at 4:42 PM
News IconEdwards Lifesciences Corporation (EW) Stake Held by Mandatum Life Insurance Co Ltd (NYSE:EW)
eleganthomesinla.com - February 18 at 4:45 PM
News IconEdwards Lifesciences Corporation (EW) Stake Maintained by Fifth Third Bancorp (NYSE:EW)
xboxonezone.com - February 18 at 4:45 PM
biz.yahoo.com logoEDWARDS LIFESCIENCES CORP Files SEC form 10-K, Annual Report (NYSE:EW)
biz.yahoo.com - February 18 at 6:06 AM
News IconWhy Investors remained confident on Omnicom Group Inc. (OMC), Edwards Lifesciences Corporation (EW)? - StockNewsJournal (NYSE:EW)
stocknewsjournal.com - February 17 at 3:19 PM
News IconRevenue Approximations Analysis: Edwards Lifesciences Corporation (EW), Ventas, Inc. (VTR) - StockNewsJournal (NYSE:EW)
stocknewsjournal.com - February 17 at 3:19 PM
fool.com logoWhy Edwards Lifesciences Could Bounce Back (NYSE:EW)
www.fool.com - February 16 at 5:03 PM
fool.com logoWhy Edwards Lifesciences Could Bounce Back (NYSE:EW)
www.fool.com - February 16 at 11:16 AM
News IconVolatility Watch on Shares of Edwards Lifesciences Corporation (NYSE:EW) - Midway Monitor (NYSE:EW)
midwaymonitor.com - February 10 at 10:39 PM
News IconRevenue Approximations Analysis: Lincoln National Corporation (LNC), Edwards Lifesciences Corporation (EW) - StockNewsJournal (NYSE:EW)
stocknewsjournal.com - February 10 at 10:39 PM
News IconForward Earnings Estimate of Edwards Lifesciences Corporation(EW) - Highland Mirror (NYSE:EW)
www.highlandmirror.com - February 10 at 10:39 PM
News IconShares of Edwards Lifesciences Corporation (EW) Sees Large Outflow of Money (NYSE:EW)
brassale.net - February 9 at 5:42 PM
bizjournals.com logoTechnical Reports on Medical Equipment Equities -- Edwards Lifesciences, Accuray, Hologic, and Zimmer Biomet (NYSE:EW)
www.bizjournals.com - February 9 at 5:42 PM
News IconThe William Blair Weighs in on Edwards Lifesciences Corporation's Q1 2018 Earnings (NYSE:EW)
mlbinjurynews.com - February 8 at 10:39 PM
News IconLarge Cap Medical Appliances & Equipment: Edwards Lifesciences Corporation (NYSE:EW) (NYSE:EW)
twincountynews.com - February 8 at 10:39 PM
biz.yahoo.com logoEDWARDS LIFESCIENCES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NYSE:EW)
us.rd.yahoo.com - February 8 at 10:39 PM
News IconLeerink Swann Research Analysts Decrease Earnings Estimates for Edwards Lifesciences Corporation (NYSE:EW)
cote-ivoire.com - February 7 at 11:18 PM
News IconClifford Swan Investment Counsel LLC Has $15493000 Position in Edwards Lifesciences Corporation (NYSE:EW)
xboxonezone.com - February 7 at 11:18 PM
News IconMedical Appliances & Equipment: Edwards Lifesciences Corporation (NYSE:EW) Position of the day (NYSE:EW)
twincountynews.com - February 7 at 11:18 PM
News IconThe Equities Analysts Issue Forecasts for Edwards Lifesciences Corporation's Q4 2017 Earnings (NYSE:EW)
mundoaguaysaneamiento.net - February 7 at 11:18 PM
News IconStock Price of Edwards Lifesciences Corporation (EW) Decreases -7.02% - Highland Mirror (NYSE:EW)
www.highlandmirror.com - February 7 at 6:16 PM
News IconWhy to Keeping Eye on TD Ameritrade Holding Corporation (AMTD), Edwards Lifesciences Corporation (EW)? - StockNewsJournal (NYSE:EW)
stocknewsjournal.com - February 7 at 6:16 PM
finance.yahoo.com logoEdwards Lifesciences Director Buys 3,000 Shares (NYSE:EW)
finance.yahoo.com - February 7 at 6:16 PM
News IconJust the Facts on Edwards Lifesciences Corporation (EW) - StockNewsJournal (NYSE:EW)
stocknewsjournal.com - February 6 at 11:10 AM
News IconEdwards Lifesciences Corp (EW) Holder De Burlo Group INC Trimmed Its Holding by $3.66 Million (NYSE:EW)
randolphguide.com - February 3 at 5:30 PM
us.rd.yahoo.com logo2017 Promises To Be An Interesting Year For Edwards Lifesciences (NYSE:EW)
us.rd.yahoo.com - February 2 at 10:41 PM
us.rd.yahoo.com logoEdwards Lifesciences downgraded by Leerink Partners (NYSE:EW)
us.rd.yahoo.com - February 2 at 10:41 PM
News IconEdwards Lifesciences Corporation (EW) Cut to "Neutral" at BTIG Research (NYSE:EW)
eleganthomesinla.com - February 2 at 5:38 PM
News IconEdwards Lifesciences Corporation (NYSE:EW) price reactions to earnings announcements (NYSE:EW)
thecelebritytruth.com - February 2 at 5:38 PM
News IconEdwards Lifesciences Corporation (EW) Releases FY17 Earnings Guidance (NYSE:EW)
mundoaguaysaneamiento.net - February 2 at 5:38 PM
us.rd.yahoo.com logoEdited Transcript of EW earnings conference call or presentation 1-Feb-17 10:00pm GMT (NYSE:EW)
us.rd.yahoo.com - February 2 at 5:38 PM
capitalcube.com logoEdwards Lifesciences Corp. :EW-US: Earnings Analysis: Q4, 2016 By the Numbers : February 2, 2017 (NYSE:EW)
us.rd.yahoo.com - February 2 at 5:38 PM
capitalcube.com logoEdwards Lifesciences Corp. :EW-US: Earnings Analysis: 2016 By the Numbers : February 2, 2017 (NYSE:EW)
us.rd.yahoo.com - February 2 at 5:38 PM
cnbc.com logoEdwards Lifesciences shares fall more than 8% despite earnings beat (NYSE:EW)
www.cnbc.com - February 2 at 12:31 PM
rttnews.com logoEdwards Lifesciences Corp. Bottom Line Rises 13% In Q4 (NYSE:EW)
www.rttnews.com - February 2 at 3:45 AM
reuters.com logoEdwards Lifesciences fourth-quarter sales, profit top expectations (NYSE:EW)
www.reuters.com - February 2 at 3:45 AM
seekingalpha.com logoEdwards Lifesciences (EW) Q4 2016 Results - Earnings Call Transcript (NYSE:EW)
seekingalpha.com - February 2 at 3:45 AM
biz.yahoo.com logoQ4 2016 Edwards Lifesciences Corp Earnings Release - After Market Close (NYSE:EW)
us.rd.yahoo.com - February 2 at 3:45 AM
us.rd.yahoo.com logoEdwards Lifesciences Reports Fourth Quarter Results (NYSE:EW)
us.rd.yahoo.com - February 2 at 3:45 AM
wsj.com logo[$$] Edwards Lifesciences Revenue Rises (NYSE:EW)
us.rd.yahoo.com - February 2 at 3:45 AM
us.rd.yahoo.com logo4:25 pm Edwards Lifesciences beats by $0.03, beats on revs; guides Q1 EPS in-line, revs in-line; reaffirms FY17 EPS, revs guidance (NYSE:EW)
us.rd.yahoo.com - February 2 at 3:45 AM
us.rd.yahoo.com logoEdwards Lifesciences 4th-quarter sales, profit top expectations (NYSE:EW)
us.rd.yahoo.com - February 2 at 3:45 AM
seekingalpha.com logoEdwards Lifescienes +1% after beat, positive outlook - Seeking Alpha (NYSE:EW)
seekingalpha.com - February 1 at 5:42 PM
News IconEdwards Lifesciences Corporation (NYSE:EW) to Post $0.71 Earnings Per Share: Analysts - Wall Street Beacon (NYSE:EW)
wsbeacon.com - February 1 at 5:42 PM
News IconEarnings Forecast Research on Edwards Lifesciences Corporation (EW) - Highland Mirror (NYSE:EW)
www.highlandmirror.com - February 1 at 5:42 PM
nasdaq.com logoEarnings Reaction History: Edwards Lifesciences Corp., 66.7% Follow-Through Indicator, 5.7% Sensitive - Nasdaq (NYSE:EW)
www.nasdaq.com - February 1 at 5:42 PM
sg.finance.yahoo.com logoEdwards Lifesciences beats Street 4Q forecasts (NYSE:EW)
sg.finance.yahoo.com - February 1 at 5:42 PM
seekingalpha.com logoEdwards Lifesciences beats by $0.03, beats on revenue (NYSE:EW)
seekingalpha.com - February 1 at 5:16 PM
News IconSADIF Analytics releases new summary due diligence report for Edwards Lifesciences Corp ($EW). (NYSE:EW)
reports.pr-inside.com - January 31 at 5:45 PM


What is Edwards Lifesciences Corporation's stock symbol?

Edwards Lifesciences Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "EW."

When did Edwards Lifesciences Corporation's stock split? How did Edwards Lifesciences Corporation's stock split work?

Edwards Lifesciences Corporation's stock split before market open on Monday, December 14th 2015. The 2-1 split was announced on Thursday, November 19th 2015. The newly minted shares were payable to shareholders after the market closes on Friday, December 11th 2015. An investor that had 100 shares of Edwards Lifesciences Corporation stock prior to the split would have 200 shares after the split.

Where is Edwards Lifesciences Corporation's stock going? Where will Edwards Lifesciences Corporation's stock price be in 2017?

25 brokerages have issued twelve-month target prices for Edwards Lifesciences Corporation's shares. Their predictions range from $88.00 to $140.00. On average, they anticipate Edwards Lifesciences Corporation's share price to reach $116.50 in the next year.

When will Edwards Lifesciences Corporation announce their earnings?

Edwards Lifesciences Corporation is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.

What are analysts saying about Edwards Lifesciences Corporation stock?

Here are some recent quotes from research analysts about Edwards Lifesciences Corporation stock:

  • According to Zacks Investment Research, "Edwards Lifesciences ended the third quarter with earnings in line with the Zacks Consensus Estimate and revenues lagging the same. While we are concerned about the 2016 sales guidance reiteration, the upward revision in EPS expectations raises investor optimism. Although Edwards’ higher operating expenses might have made investors apprehensive, this was due to advanced initiatives to improve overall sales growth. Nevertheless, management expects to gain traction in the ever expanding TAVR market, based on increasing preference in favor of transcatheter aortic valve replacement as well as compelling clinical evidences. We are also looking forward to the strong global adoption of the company’s SAPIEN 3 platform, on track to generate over $300 million additional in sales in 2016. On the flip side, competitive headwinds and reimbursement continue to pose challenges." (10/28/2016)

  • Leerink Swann analysts commented, "We derive a $12 price target for EARS using a DCF analysis with a 13% discount rate and a 2% terminal growth rate. Our valuation assumes a 60% probability of approval for AM-101 and a 25% probability of success for AM-111. Upside to our valuation could come from both: (1) off-label use of ’101 in tinnitus of etiologies beyond otitis media and acute acoustic trauma, and (2) the ability of EARS to commercialize AM-111 in the US." (8/19/2016)

  • Canaccord Genuity analysts commented, "We expect current momentum in the US TAVI market to accelerate behind today’s announced S3 IR approval. The FDA announced approval of an expanded indication for EW’s Sapien 3 and Sapien XT valves for the treatment of intermediate risk patients (i.e. STS score 3-10), with S3 and XT representing the first valves approved in the US for use in IR patients." (8/18/2016)

Who owns Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (4.32%), Sands Capital Management LLC (3.90%), FMR LLC (3.22%), Franklin Resources Inc. (1.25%), Janus Capital Management LLC (1.09%) and Disciplined Growth Investors Inc. MN (1.00%). Company insiders that own Edwards Lifesciences Corporation stock include Barbara J Mcneil, Catherine M Szyman, Donald E Bobo Jr, Donald E Bobo, Jr, Dylan Sidoo, Huimin Wang, John T Cardis, Kieran Gallahue, Larry L Wood, Michael A Mussallem, Nick Demare, Patrick B Verguet, Robert Marc Bustin, Robert WA Sellers, Schack Wesley W Von, Steven R Loranger and West Petroleum Corp East.

Who sold Edwards Lifesciences Corporation stock? Who is selling Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Sands Capital Management LLC, Renaissance Technologies LLC, AQR Capital Management LLC, Credit Agricole S A, Franklin Resources Inc., Castleark Management LLC and Disciplined Growth Investors Inc. MN. Company insiders that have sold Edwards Lifesciences Corporation stock in the last year include Donald E Bobo Jr, Donald E Bobo, Jr, Huimin Wang, John T Cardis, Larry L Wood, Michael A Mussallem, Patrick B Verguet, Robert WA Sellers and Schack Wesley W Von.

Who bought Edwards Lifesciences Corporation stock? Who is buying Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Marshall Wace LLP, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Fred Alger Management Inc., State Street Corp, Brown Advisory Inc., Asset Management One Co. Ltd. and William Blair Investment Management LLC. Company insiders that have bought Edwards Lifesciences Corporation stock in the last two years include Catherine M Szyman, Dylan Sidoo, Kieran Gallahue, Nick Demare, Robert Marc Bustin, Steven R Loranger and West Petroleum Corp East.

How do I buy Edwards Lifesciences Corporation stock?

Shares of Edwards Lifesciences Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Edwards Lifesciences Corporation stock cost?

One share of Edwards Lifesciences Corporation stock can currently be purchased for approximately $92.67.

Edwards Lifesciences Corporation (NYSE:EW) Chart for Tuesday, February, 21, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Edwards Lifesciences Corporation (NYSE:EW)

Earnings History Chart

Earnings by Quarter for Edwards Lifesciences Corporation (NYSE:EW)

Dividend History Chart

Dividend Payments by Quarter for Edwards Lifesciences Corporation (NYSE:EW)

Last Updated on 2/21/2017 by MarketBeat.com Staff